"Nostrum Laboratories has recalled all bottles of 1 gram Sulcralfate Tablets, emphasizing it cannot guarantee the product's effectiveness or purity."
"After filing for Chapter 11 bankruptcy, Nostrum's operations ceased, resulting in the firing of all employees and a lack of quality control."
Nostrum Laboratories has recalled all 1 gram Sulcralfate Tablets because it cannot assure the product's identity, strength, quality, or purity. Following a Chapter 11 bankruptcy filing, all operational employees were terminated on September 30, 2024, leading to a vacancy in quality control. This affects tablets manufactured after June 2023. The National Library of Medicine describes Sulcralfate for short-term treatment of duodenal ulcers. Wholesalers and distributors are instructed to destroy the recalled product as Nostrum will not accept returns.
Read at Miami Herald
Unable to calculate read time
Collection
[
|
...
]